Is Curative Biotechnology Stock a Good Investment?
Curative Biotechnology Investment Advice | CUBT |
- Examine Curative Biotechnology's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Curative Biotechnology's leadership team and their track record. Good management can help Curative Biotechnology navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Stock space and any emerging trends that could impact Curative Biotechnology's business and its evolving consumer preferences.
- Compare Curative Biotechnology's performance and market position to its competitors. Analyze how Curative Biotechnology is positioned in terms of product offerings, innovation, and market share.
- Check if Curative Biotechnology pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Curative Biotechnology's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Curative Biotechnology stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Curative Biotechnology is a good investment.
Sell | Buy |
Strong Sell
Market Performance | OK | Details | |
Volatility | Out of control | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | High | Details | |
Economic Sensitivity | Very regressive towards the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Examine Curative Biotechnology Stock
Researching Curative Biotechnology's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). The company recorded a loss per share of 0.01. Curative Biotechnology had not issued any dividends in recent years. The entity had 1:400 split on the 2nd of December 2022.
To determine if Curative Biotechnology is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Curative Biotechnology's research are outlined below:
| Curative Biotechnology is way too risky over 90 days horizon | |
| Curative Biotechnology has some characteristics of a very speculative penny stock | |
| Curative Biotechnology appears to be risky and price may revert if volatility continues | |
| Curative Biotechnology has high likelihood to experience some financial distress in the next 2 years | |
| Curative Biotechnology currently holds 2.26 M in liabilities with Debt to Equity (D/E) ratio of 6.6, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Curative Biotechnology has a current ratio of 0.1, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Curative Biotechnology's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 132.32 K. Net Loss for the year was (3.96 M) with profit before overhead, payroll, taxes, and interest of 100.21 K. | |
| Curative Biotechnology currently holds about 126.85 K in cash with (486.58 K) of positive cash flow from operations. |
Curative Biotechnology's market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 11.29 M.Basic technical analysis of Curative Stock
As of the 7th of February, Curative Biotechnology shows the Downside Deviation of 14.7, risk adjusted performance of 0.1004, and Mean Deviation of 10.41. Curative Biotechnology technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Understand Curative Biotechnology's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Curative Biotechnology's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.1004 | |||
| Market Risk Adjusted Performance | (1.25) | |||
| Mean Deviation | 10.41 | |||
| Semi Deviation | 11.27 | |||
| Downside Deviation | 14.7 | |||
| Coefficient Of Variation | 912.38 | |||
| Standard Deviation | 15.08 | |||
| Variance | 227.5 | |||
| Information Ratio | 0.1031 | |||
| Jensen Alpha | 1.76 | |||
| Total Risk Alpha | 0.0525 | |||
| Sortino Ratio | 0.1058 | |||
| Treynor Ratio | (1.26) | |||
| Maximum Drawdown | 85.65 | |||
| Value At Risk | (24.17) | |||
| Potential Upside | 26.36 | |||
| Downside Variance | 216.16 | |||
| Semi Variance | 127.02 | |||
| Expected Short fall | (13.64) | |||
| Skewness | 0.5675 | |||
| Kurtosis | 2.03 |
| Risk Adjusted Performance | 0.1004 | |||
| Market Risk Adjusted Performance | (1.25) | |||
| Mean Deviation | 10.41 | |||
| Semi Deviation | 11.27 | |||
| Downside Deviation | 14.7 | |||
| Coefficient Of Variation | 912.38 | |||
| Standard Deviation | 15.08 | |||
| Variance | 227.5 | |||
| Information Ratio | 0.1031 | |||
| Jensen Alpha | 1.76 | |||
| Total Risk Alpha | 0.0525 | |||
| Sortino Ratio | 0.1058 | |||
| Treynor Ratio | (1.26) | |||
| Maximum Drawdown | 85.65 | |||
| Value At Risk | (24.17) | |||
| Potential Upside | 26.36 | |||
| Downside Variance | 216.16 | |||
| Semi Variance | 127.02 | |||
| Expected Short fall | (13.64) | |||
| Skewness | 0.5675 | |||
| Kurtosis | 2.03 |
Consider Curative Biotechnology's intraday indicators
Curative Biotechnology intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Curative Biotechnology stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.09 | |||
| Day Median Price | 0.0125 | |||
| Day Typical Price | 0.0125 | |||
| Price Action Indicator | 5.0E-4 | |||
| Period Momentum Indicator | 0.001 |
Curative Stock media impact
Far too much social signal, news, headlines, and media speculation about Curative Biotechnology that are available to investors today. That information is available publicly through Curative media outlets and privately through word of mouth or via Curative internal channels. However, regardless of the origin, that massive amount of Curative data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Curative Biotechnology news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Curative Biotechnology relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Curative Biotechnology's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Curative Biotechnology alpha.
Curative Biotechnology Corporate Management
| BS BA | Vice Officer | Profile | |
| Pam Bisikirski | Vice Communications | Profile | |
| JD Esq | CFO, CEO | Profile | |
| Ronald Bordens | Executive Board | Profile |
Additional Tools for Curative Stock Analysis
When running Curative Biotechnology's price analysis, check to measure Curative Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Curative Biotechnology is operating at the current time. Most of Curative Biotechnology's value examination focuses on studying past and present price action to predict the probability of Curative Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Curative Biotechnology's price. Additionally, you may evaluate how the addition of Curative Biotechnology to your portfolios can decrease your overall portfolio volatility.